Apollo Hospitals Share Price Target: Morgan Stanley has reviewed the stock of Apollo Hospitals and slashed the target price due to margin pressures.
The brokerage noted that EBITDA estimates are cut due to ramp-up losses in new hospitals.
- Higher operating costs in Apollo 24/7 impacting profitability
- EPS estimates reduced ~2.5-3% for FY27-28
- Revenue outlook unchanged, but margin pressures persist
Apollo Hospitals Share Price Target 2026
Morgan Stanley maintained Overweight rating with a target price of Rs 8,833, cut from Rs 9,209.
Apollo Hospitals Share Price
On Wednesday, the hospital stock closed at Rs 7332, down 0.49 per cent from its previous closing, on BSE.
Apollo Hospitals Q3 Results FY26
Apollo Hospitals in February posted a 35 per cent increase in consolidated profit after tax (PAT) to Rs 502 crore in the December quarter, led by strong performances across three business verticals.
The healthcare provider had reported a PAT of Rs 372 crore in the October-December quarter of the last fiscal year. The revenue increased to Rs 6,477 crore for the third quarter as compared with Rs 5,527 crore in the year-ago period.
Consolidated revenue of the healthcare services division grew 14 per cent to Rs 3,183 crore during the quarter compared to Rs 2,785 crore a year ago.
The company said its board has declared an interim dividend of Rs 10 per share for the financial year ending March 31, 2026.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money related decisions.)
Read more news like this on www.etnownews.com